Wooree BIO
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Wooree BIO makes health-supplement foods, products formulated with functional ingredients designed to support wellness beyond ordinary nutrition, along with flexible circuit boards, LED lighting components, and LED backlighting assemblies for televisions.
Its supplements are approved by Korea's Ministry of Food and Drug Safety and are distributed under its own consumer brands. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across five distinct business divisions rather than concentrating on a single product line.
Summary is AI-generated and may contain errors · figures from DART filings
Certain of its health-supplement products are made under individually recognised ingredient approvals, which grant the holder exclusive rights to use those specific functional ingredients in Korea.
Wooree BIO in five facts
What does Wooree BIO do?
Wooree BIO makes health-supplement foods, products formulated with functional ingredients designed to support wellness beyond ordinary nutrition, along with flexible circuit boards, LED lighting components, and LED backlighting assemblies for televisions.
Where is Wooree BIO listed and in which sector?
Wooree BIO (Korean name: 우리바이오) trades under KRX code 082850 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Wooree BIO?
Its market capitalisation was US$32.5M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Wooree BIO's latest annual revenue and operating profit?
For fiscal year 2025, Wooree BIO reported revenue of US$787.9M, operating profit of US$718.9K and a net loss of US$7.7M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was down 15.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Trading suspension liftedSep 4
- Trading suspension (share consolidation/split registration)
Wooree BIO's common shares will be suspended from trading starting 2026-08-14 through the day before the amended share certificates are listed, due to a share consolidation.
M&A · Aug 11 - Cash/in-kind dividend decision
Wooree BIO declared a cash dividend of US$0.01 per share, equal to about 1.2% of the recent share price.
Dividend · Mar 12 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Wooree BIO updated its previously filed consolidated results for FY2025: revenue of US$713M (−15.62% year on year), operating profit of US$650K (−93.74% year on year) and a net loss of US$6.95M (from a profit a year earlier).
Earnings · Mar 10 · 2 versions